Successful treatment of refractory palmoplantar pustulosis with apremilast
Author:
Affiliation:
1. Dermatology Department; University Hospital Wales; Cardiff UK
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ced.13065/fullpdf
Reference6 articles.
1. Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion;Sevrain;J Eur Acad Dermatol Venereol,2014
2. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial;Papp;J Am Acad Dermatol,2015
3. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2);Paul;Br J Dermatol,2015
4. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2);Rich;J Am Acad Dermatol,2016
5. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis;Bissonnette;J Am Acad Dermatol,2016
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Apremilast or Methotrexate: The Arrows in the Quiver for Psoriasis;Cureus;2023-05-09
2. Apremilast;TURKDERM;2022-05-05
3. Successful Treatment of Palmoplantar Pustulosis With Apremilast;J DRUGS DERMATOL;2021
4. The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios;Psoriasis: Targets and Therapy;2021-08
5. A multicentre open‐label study of apremilast in palmoplantar pustulosis (APLANTUS);Journal of the European Academy of Dermatology and Venereology;2021-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3